Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback